Introduction 96
Successful interactions with the environment -those that maximise reward and minimise 97 punishment -entail using previous experience to predict the likely value of outcomes and the 98 actions that obtain them. Animal and human studies have strongly implicated the 99 neurotransmitter dopamine in this value learning process (Bayer and Glimcher, 2005; Schultz, Pessiglione et al., 2006) , in addition to its other overlapping roles in shaping 102 behaviour, including motivation (Berridge and Robinson, 1998) , vigour (Niv et al., 2007) and 103 behavioural activation (Robbins and Everitt, 2007) . 104
But choice requires not merely an ability to predict the consequences of one's actions. One must 105 be able to weigh up the likely values of competing possibilities. Thus, it is critical to retrieve and 106 represent the subjective values of the options on offer in order to select the most valuable one. 107
This value computation -an intrinsic part of decision-making -has been linked to the function 108 of certain key brain regions in humans and non-human primates, including the ventromedial 109 prefrontal cortex (vmPFC), ventral striatum, posterior parietal and supplementary motor cortex 110 whether value-related processes in these regions may be modulated by dopamine. 113
Single cell recordings from dopamine neurons responding to reward-predicting stimuli have 114 implicated dopamine in the neural coding of the subjective value of stimuli (Fiorillo et al., 2003; 115 Roesch et al., 2007; Tobler et al., 2005) . Furthermore, recent pharmacological studies suggested 116 a role of dopamine in the optimal selection of most valuable stimuli within probabilistic learning 117 tasks (Jocham et al., 2011; Shiner et al., 2012; Smittenaar et al., 2012) . However, there is a 118 critical distinction between value updating (learning) and value-based decision-making, and 119 these cannot be fully dissociated within probabilistic learning tasks. Whereas both processes 120 are hypothesised to be modulated by dopamine (McClure et al., 2003) , the distinct role of dopamine in decision-making, dissociated from learning, has not been experimentally 122 investigated. To address this, we conducted a between-subject, placebo-controlled 123 pharmacological fMRI study in healthy volunteers. 124
We explored the effects of both a dopamine agonist and an antagonist on the subjective 125 valuation of food items in a Becker-deGroot-Marschak (BDM) mechanism (Becker et al., 1964) . 126
The BDM replicates many aspects of second-price auctions and provides a robust means of 127
obtaining subjective values and involves no learning component. It has been used in human 128 neuroscience before (Grether et al., 2007; Plassmann et al., 2007) . All items in the auction were 129 well-known everyday foods whose value subjects would have acquired through life experience, 130 independent of our experimental manipulation. This enabled us to characterise the impact of 131 dopaminergic modulation on the behavioural and brain processes associated primarily with 132 decision-making. 133
Materials and methods 135
Subjects 136
Forty-seven healthy, right-handed people (23 males, aged 23.8±3.2, body mass index 21.7±1.6 137 kg/m 2 (mean±SD)) participated in the study. All subjects had normal or corrected to normal 138 vision, had no history of psychiatric or other significant medical history, and reported no 139 contraindications to the pharmacological agents or MRI scanning. 140
The study was approved by the Cambridge East Local Research Ethics Committee (REC 141 11/EE/0480) and was conducted at the Wellcome Trust Clinical Research Facility and the 142 Wolfson Brain Imaging Centre in Addenbrooke's Hospital, Cambridge, UK. The study was 143 carried out in accordance with the principles of the Declaration of Helsinki. All participants 144 provided written, informed consent. 145
Study design 146
In a double-blind, between-subject study, subjects received a single oral dose of either 147 bromocriptine 1.25 mg (dopamine D2 agonist, n=15), sulpiride 400 mg (D2 antagonist, n=16) or 148 placebo (n=16). One subject (from the sulpiride group) did not pay attention to the task and was 149 excluded from the analysis (on over 50% of the free trials, the subject placed a bid of £0; when 150 debriefed, she did not express any dislike of the food items on offer or a desire to keep her 151 budget, thus calling into question her understanding of the task). Three additional subjects (one 152 from each group) were excluded from the fMRI analysis because of severe signal dropout in the 153 frontal lobe, as agreed on visual inspection by the study analysis team. This left 46 datasets (23 154 males, aged 23.8±3.2, body mass index 21.7±1.6 kg/m 2 (mean±SD)) for the behavioural analysis 155 and 43 datasets (21 males, aged 23.6±2.9, body mass index 21.5±1.5 kg/m 2 (mean±SD)) for the 156 fMRI analysis. Subjects' age (F = 0.45, p = 0.64), BMI (F = 1.02, p = 0.37) or gender ( 2 = 0.04, p = 157 0.98) did not differ between the treatment groups. In addition to the task described below, 158 participants underwent a number of other cognitive measures, which are not presented here.
Subjects attended the study session in the morning following an overnight fast. They received a 160 standardised breakfast (based on body weight, age and gender) on the clinical research facility 161 at 8am. This was to ensure similar baseline metabolic states across subjects and to minimise 162 pharmacokinetic perturbations related to food and drink. 163
Bromocriptine and sulpiride have been used in previous studies (Cools et al., 2009; Dodds et al., 164 2009; Morcom et al., 2010) , and are well tolerated at these doses. As bromocriptine can cause 165 nausea (Bromocriptine SPC, 2012), to maintain the double-blinding and prevent any effects of 166 nausea on performance on a food-related task, all subjects were prophylactically given 10 mg of 167 the anti-emetic domperidone, which does not cross the blood-brain barrier (Domperidone SPC, 168 2012). Bromocriptine reaches peak plasma levels 1-3 hours post dose, with a half-life of about 169 15 hours (Kvernmo et al., 2006) . Sulpiride reaches its maximal plasma concentration about 3 170 hours post dose, and has a plasma half-life of about 12 hours (Caley and Weber, 1995; Wiesel et 171 al., 1980) . The study drug and domperidone were given to all participants at 11am. The fMRI 172 acquisition started approximately 2.5 hours after receiving the drugs (at ~1:30 pm) to capture 173 the window of maximal drug effect. 174
fMRI task 175
A computerised version of the BDM auction was developed, in which participants could bid for 176 50 different foods, represented by photographs (see Figure 1A ). Participants were given a fixed 177 budget, and the auction procedure incentives participants to place bids as close as possible to 178 their real subjective value. 179
In addition to their study participation fee, before entering the scanner, participants were 180 handed a budget of £3 for bidding. This was physically given to them to ensure they regarded 181 the budget as their own money. They were instructed that on each trial they could place a bid 182 between £0 and £3 for the presented item. Responses were made on a sliding scale that went 183 from £0 to £3 in increments of 20 pence. Participants were told that the computer would bid 184 against them on each trial but the bid would not be disclosed to them. As per the rules of the auction, one trial would be randomly selected at the end of the auction (subjects therefore did 186 not have to spread their £3 budget across different trials, and were instructed to treat every 187 trial as if it were the only one). If their bid for the food item on the selected trial was larger than 188 the computer's, they would win that food item, get a chance to eat it after the scanning session 189 and only have to pay the amount the computer bid (which would be less than their bid) and 190 keep any remaining change. If, however, the computer outbid them or matched their bid, they 191 would not win the food item but would get to keep their £3 budget. Given this set-up, the 192 auction is incentive-compatible, i.e. the best strategy is to place a bid close to what one is 193 actually willing to pay. As the actual amount paid is determined by the computer's bid on the 194 selected trial, bidding higher amounts risks having to pay more than one's subjective value. 195
Bidding lower amounts runs the risk of losing the opportunity to win the item (more cheaply 196 than one was prepared to pay for it). These rules were all explicitly stated and emphasised to 197 the subjects as part of the task instructions. Critically, participants were in a hungry state and 198 were told that they could eat any food they won after the scanning session. 199
Since each trial entails a number of perceptuomotor components, we used an approach taken by 200 Plassmann et al., (2007) , by including a control task in which the same 50 foods were presented 201 in "forced" trials (as opposed to the above "free" trials) where subjects were instructed to bid an 202 amount taken from a random distribution of possible bids from £0 to £3 pounds, again in 20 203 pence increments. These trials required participants to engage in all the processes involved in 204 the free trials with the critical difference of requiring no subjective valuation. Moreover, 205 participants were aware that they would not lose money on such trials. 206
Fifty trials of each trial type (free and forced), of duration 8 seconds, were presented in a 207 randomised order. The picture of the food was presented throughout the entire 8-second 208 duration of a trial. The initial position of the cursor on the sliding scale varied randomly. 209
Participants placed bids using a standard button box with the first and second buttons serving 210 to move the cursor down or up the sliding value scale in steps of 20 pence, and the third button serving to confirm the final bid and mark the end of the bidding. From this point until the end of 212 the 8-second bidding trial, the cursor could not be moved further. When the 8-second bidding 213 trial was over, a feedback screen showing the final bid was presented ( Figure 1A ). If the bid was 214 not confirmed within 8 seconds, the feedback screen stated "Not quick enough". In the analysis, 215 these trials were considered missed trials. 216
In fact, for practical reasons, the task was set up to ensure that subjects did not win a food item, 217 but instead ended up keeping their £3 budget. 218
Behavioural analysis 219
Behavioural data were analysed using mixed-effects models (nlme package in R (Pinheiro et al., 220 2013)), with subjects as a random effect. Post-hoc comparisons, where needed, were done using 221 the multcomp package (Hothorn et al., 2008) . Images were realigned then spatially normalised to a standard template and spatially smoothed 232 with an isotropic 3 dimensional Gaussian filter (8 mm full width at half maximum). The time 233 series in each session were high-pass filtered (with cut-off frequency 1/120 Hz) and serial 234 autocorrelations were estimated using an AR(1) model. 235
Model 1: Brain responses to value across the entire bidding period and its modulation by 237 dopamine 238
Each bidding trial was modelled as a boxcar function, from the onset of the food stimulus until 239 the bid was confirmed (duration equal to RT, Figure 1B ). Separate regressors were created for 240 free and forced trials. Free and forced bids were used as parametric modulators of these 241 regressors. Missed trials (in which no bids were selected within 8 seconds) were modelled as a 242 separate regressor. All regressors were convolved with a canonical haemodynamic response 243 function with a temporal derivative. Six motion realignment parameters were included as 244 regressors of no interest. 245
To examine processes specifically associated with valuation, we calculated the first-level 246 contrasts as the difference between the parametric modulator of free bid in free trials and 247 forced bid in forced trials. Given that in forced trials subjects implemented instructed bids, these 248 trials should not engage the circuitry of interest to us but they should engage all other non-249 specific processes related to valuation. The applied contrast thus corrects for non-specific 250 effects and enables identification of regions specifically involved in the valuation-based decision 251 process. Single-subject contrast images were then entered into a second-level group analysis, 252 with subjects as a random effect. given the strong evidence implicating this region in value computation. In addition, we explored 260 the existence of value related signals across the whole brain, adopting a threshold of p<0.05, FWE corrected at the cluster-level. Additionally, for completeness, we explored the existence of 262 brain regions whose neural activity separately correlated with free bids in free trials and forced 263 bids in forced trials. We also explored whether there was a region whose activity tracked the 264 mismatch between free bid and the randomly ascribed forced bid for the same food item during 265 forced trials; this entailed examining the existence of correlation between neural activity during 266 forced trials and a parametric modulator of the difference between the free bid and the randomly 267 ascribed forced bid for same food item. These additional analyses were conducted at the whole-268 brain level, using a more liberal threshold of p<0.001, uncorrected. 269 2. To explore the effect of the dopaminergic modulation on the neural representation of value, 270
we performed a non-directional F-test (ANOVA). This was again conducted within the vmPFC 271 ROI, applying a small-volume corrected threshold of p<0.05, and at the whole-brain level, at a 272 more liberal threshold of p<0.001 uncorrected, k>20 voxels. This threshold at the whole-brain 273 level was adopted because it is not possible to apply a cluster-level correction for F-tests in 274 SPM8 and a voxel-level correction would be too stringent. In case of significant effects, they 275 were further delineated using two-sample t-tests at the whole-brain cluster-level and within the 276 vmPFC sphere, at a FWE corrected threshold of p<0.05. 277
278

Model 2: Does dopamine have different contributions to different phases of the 279 bidding/valuation process? 280
This post-hoc analysis aimed to establish the temporal specificity of the dopaminergic effects 281 and, in so doing, to relate them to the early (initial valuation) and late (value-dependent action) 282 stages of the bidding process. A modified first-level model was estimated that looked for 283 changes in the correlation of BOLD activity with the bid separately for early and late phases of 284 each trial. 285
286
To model the early and late stages of the bidding process, two regressors were created for each subject. These two regressors were modelled as 0s stick functions: an early period regressor 288 was set at the time of food photo (and trial) onset, and a late period regressor was set at a time 289 half-way from the food photo onset to the bid confirmation (RT/2). This was done separately 290 for each trial ( Figure 1C ). Whereas at the first time point no responding took place, at the 291 second time point, participants were responding to select the bid. Missed early and late 292 regressors were modelled as separate 0s stick functions, with the late time point regressor 293 modelled at 4s (halfway through the trial). The parametric modulators of bids for early and late 294 time points were the same for a given trial. To identify neural representations of value at each 295 time point, two separate single-subject contrasts were computed: the early neural 296 representation of value as the difference between the parametric modulator of free bid and 297 forced bid at the early time point; and the late neural representation as the difference between 298 the parametric modulator of free bid and forced bid at the late time point. 299
300
The two contrast images per each individual were put forward to the second-level group 301 analysis, with subjects as a random effect. At the group level we used a 2x3 factorial ANOVA to 302 explore the interaction between time and drug on the neural representation of value. This 303 analysis was confined to a 10mm-radius sphere around the peak voxel exhibiting the strongest 304 dopaminergic modulation of neural representation of value, established in the previous 305 analysis. The analysis was conducted at a FWE small-volume corrected threshold of p<0.05. 306
Results 308
Behavioural results 309
Missed trials 310
Predictably, there were significantly fewer missed trials within the free than in the forced trials 311 (free (mean±SEM): 0.48± 0.12, forced (mean±SEM): 1.52± 0.27, F=17.49, p=0.0001), however 312 this did not differ across groups (trial type-by-group interaction F=0.14, p=0.87). 313
Bid 314
Despite a clear trend for higher free bids in the sulpiride group (Figure 2A) , the effect of 315 treatment did not reach significance (F=2.83, p=0.07). Pairwise comparisons revealed a 316 strongest difference between sulpiride and bromocriptine, however this did not reach 317 significance (sulpiride versus bromocriptine, z=2.16; p=0.08, placebo versus bromocriptine 318 z=0.23, p=0.97; sulpiride versus placebo z=1.96, p=0.12, Tukey-corrected for multiple 319 comparisons). 320
Free bids were found to be positively correlated with the initial random position of cursor on 321 the bidding scale (t=6.09, p<0.0001), however, this did not differ between different treatment 322 groups (initial cursor position-by-treatment group interaction F=1.76, p=0.17). Adding the 323 initial cursor position as the covariate into the model exploring the effect of treatment group on 324 the bid did not change the reported results. 325
Reaction time 326
Individual reaction times (RTs) were, of course, dependent on the initial position of the cursor 327 since this would determine how far they were required to move in order to finalise the 328 selection. There was thus a correlation between starting point and RT (t=10.15, p<0.0001). To 329 account for this, the number of button presses made to select the bid was entered as a covariate 330 into the model exploring the effect of trial type and drug treatment on RT. The analysis revealed a significant effect of trial type (F=398.39, p<0.0001), with subjects, as expected, being quicker 332 on forced compared to free trials ( Figure 2B ). There was no main effect of treatment (F=1.01, 333 p=0.37), however there was a significant treatment-by-trial type interaction (F=3.7, p=0.025). 334
None of the pairwise comparisons between drug treatments in the free condition reached 335 significance, however, as evident from the plot, there was a trend of shorter RTs under sulpiride 336 in comparison to placebo and bromocriptine (placebo versus bromocriptine z=0.47, p=0.86; 337 sulpiride versus bromocriptine z=-1.29, p=0.39; sulpiride versus placebo z=-1.78, p=0.18; 338
Tukey corrected for multiple comparisons). As evident from the plot, the analogous analysis 339 within the forced trials revealed no difference in reaction RTs between drug treatments 340 (placebo versus bromocriptine z=-0.46, p=0.89; sulpiride versus bromocriptine z=-0.85, p=0.67; 341 sulpiride versus placebo z=-0.41, p=0.91; Tukey corrected for multiple comparisons). 342 fMRI results 343
As described above, two key analyses were performed. Our first analysis treated the entire 344 duration of the bidding (equal to RT, mean RT±SD = 4.1±1.37s) as the period of interest to 345 identify regions sensitive to value and dopaminergic modulation (Model 1, Figure 1B ). Next we 346 sought to determine whether in these regions, there were differential effects of dopamine on 347 different aspects of the bidding process (Model 2, Figure 1C ). Model 2 examined whether the 348 drug effects were specific to a particular stage of each trial. Dividing every trial into early and 349 late phases (corresponding approximately to initial valuation and value-dependent action) on 350 the basis of the response made, we explored the interaction between drug, value (bid size) and 351 trial phase (early versus late). 
The neural representation of value (Model 1) 357
Examination of the brain regions involved in valuation across all study participants revealed 358 activity correlating with subjective value within the pre-defined region of vmPFC (pFWE<0.05, 359 small volume corrected, Figure 3A Figure 3B and Table 1) . 365
For completeness, we conducted two additional analyses. Firstly, we explored the correlation of 366 neural activity with free and forced bids separately. Whereas the neural activity correlating with 367 free bids in free trials mimicked the pattern of neural activity in our main contrast, there was no 368 region, even at a liberal threshold of p<0.001 uncorrected, whose activity correlated with forced 369 bids in forced trials. This confirms that the effects established in our main contrast were not 370 driven by activity associated with forced trials. Secondly, we also investigated whether there 371 was a region whose activity tracked the mismatch between free bid and the randomly ascribed 372 forced bid for the same food item during forced trials. That is, we determined whether being 373 forced to make a bid that markedly deviated from how one would normally value a given item 374 was associated with enhanced responses. However, no such region was detected, even at a 375 liberal threshold of p<0.001 uncorrected. 376
Dopaminergic drugs modulate the neural response to value in the left and right inferior 377 parietal gyrus/intraparietal sulcus (Model 1) 378
We next explored the effect of the administered dopaminergic drugs on the valuation-379 dependent brain activity. The ANOVA comprising the three levels of pharmacological treatment 380 found no effect of treatment in the vmPFC (this was also true for a more liberal threshold, p<0.001 uncorrected). A significant effect of dopaminergic treatment was found in the right 382 middle frontal gyrus and in the left and right inferior parietal gyrus, in close vicinity of the IPS 383 (IPG/IPS; p<0.001 uncorrected, k>20 voxels; Table 2, Figure 4A ). 384
To establish more precisely what drove this effect, additional two-sample t-tests were 385 performed. Compared to sulpiride, bromocriptine was associated with a stronger relationship 386 between value and activity in the IPG/IPS bilaterally (corrected for multiple comparisons at the 387 cluster-level, pFWE<0.05, Table 3 , Figures 4B and 4D) ; in other words, it increased the strength of 388 correlation between the bids and the BOLD response. Further t-tests between individual 389 pharmacological treatments did not reveal any significant clusters at the same threshold. 390
Interestingly, these two clusters were close to the posterior parietal cluster identified in the 391 previous contrast. As can be seen from the parameter estimates ( Figure 4C ), there was a trend 392 towards reduced neural representation of value within the sulpiride group in the posterior 393 parietal cluster, however, the clear distinction between the groups was only seen in the L-and 394
R-IPG/IPS clusters. 395
In summary, we found that the neural response to value is significantly affected by 396 pharmacological manipulation of dopaminergic function in the IPG/IPS region and this effect 397 was driven by the bromocriptine versus sulpiride contrast. 398
Dopaminergic treatment modulates the neural representation of value in the left inferior 399 parietal gyrus/intraparietal sulcus during the late stage of valuation (Model 2) 400
Here, we investigated whether the dopaminergic modulation is specific to the early or late stage 401 of the valuation process. We focused specifically on the regions showing an effect of drug across 402 the whole trial, splitting this trial into early and late phases (with the split-point determined 403 based on time-to-decision for each trial separately). A significant time-by-drug interaction was 404 established in a 10mm-radius sphere around the peak voxel in the left IPG/IPS demonstrating 405 the strongest effect of dopaminergic treatment in the previous model (pFWE<0.05, small volume corrected, Table 4, Figure 5A ). As evident from the parameter estimates extracted from each of 407 six conditions ( Figure 5B ), the effect of dopaminergic manipulation on valuation was greater 408 during the later (value-dependent action) phase compared to the earlier (initial valuation) 409
phase. This result suggests that the modulation of strength of correlation between the bids and 410 the BOLD signal in the left IPG/IPS, increasing with bromocriptine and decreasing with 411 sulpiride, becomes more pronounced closer to the point when an appropriate action is used to 412 record the final bid, i.e. when the participant makes a fine-grained decision about whether the 413 bid should be 20p more or less, which in the context of our task might indicate a dopaminergic 414 influence on the fine tuning of the valuation process. 415
Discussion 417
In this pharmacological fMRI study we used the established BDM mechanism with food rewards, 418 in a sample of hungry participants, to assess the role of dopamine in subjective valuation. We 419 characterised the effects of dopaminergic modulation, using both an agonist and an antagonist, 420 demonstrating its role in the coding of value in the IPS. Compared to sulpiride, bromocriptine 421 enhanced the neural representation of value in the IPS. Moreover, a significant drug-by-value-422 by-trial phase interaction indicated that the dopaminergic modulation of neural response was 423 specific to the late phase of the trials, when an action was needed to record the value. expressed during the learning phase also predicted choice in the performance phase). Our 435 results concur with these findings, and complement them by demonstrating a dopaminergic 436 component of value computation in response to already well-learned items. Furthermore, the 437 realistic nature of the task and the inclusion of highly-familiar foods as auction items more 438 closely mimics every day value computations we make, which, compared to choosing between 439 probabilistic stimulus-reward associations, are more complex and are thought to entail 440 integration of various attributes into a single measure of subjective value, which can be then 441 used as input for making choices (Rangel et al., 2008) . computation is being processed in the IPS. We are cautious about interpreting a null effect in 449 vmPFC but it is worth noting that the association of BOLD activity in this region with value has 450 been generally established at the initial stages of the decision-making process and is thought to 451 serve as an input to later stages of decision-making (Rangel, 2010; Rangel and Clithero, 2013) . were predictive of poorer decision-making. Our results complement these findings by directly 474
showing the effects of dopaminergic modulation on the neural representation of value. 475
Moreover, the fact that the drug modulations occurred late in the trials (i.e. close to the final 476 selection of the bid) suggests that dopamine modulates the dynamic process of fine tuning the 477 neural representation of value as the basis for completing the decision/action. 478
Behaviourally, we did not detect an effect of dopaminergic treatment on the magnitude of bids, 479 perhaps as consequence of the relatively mild pharmacological perturbation induced. However, 480 the presence of significant neural alterations in the context of matched behaviour offers some 481 advantages to interpreting the former more clearly, in keeping with previous theoretical 482 perspectives (Wilkinson and Halligan, 2004) . Moreover, to the best of our knowledge, there is 483 no data demonstrating that dopamine increases value in a context dissociated from learning, A 484 more detailed analysis of the RTs revealed that the average time to decide on the size of the bid 485 was reduced in the sulpiride condition, suggestive of decreased deliberation on the value of 486 individual foods. Interestingly, this effect was paralleled by a trend towards larger bids in the 487 sulpiride condition. In fact, the average bid under sulpiride is much closer to the mean bid in the 488 forced condition (see Figure 2A) . Given that the bids in the forced condition were taken from a 489 random, uniform distribution, we speculate that sulpiride, and the proposed decrease in SNR of 490 value representation, were associated with more random, less deliberative bids. 491 492 Finally, it is noteworthy that part of the posterior parietal region lying in close proximity to the 493 dopamine-dependent value coding region identified in this study has been found to be related to 494 goal-directed behaviour (Glascher et al., 2010) . Given that dopamine has been implicated in 495 mediating the balance between the habitual and goal-directed systems, with increased 496 dopaminergic activity shifting the behaviour towards a more dominant goal-directed control (de Wit et al., 2011 (de Wit et al., , 2012 Wunderlich et al., 2012) , and given the importance of valuation in 498 goal-directed behaviour, we speculate that our agonist and antagonist drugs shifted this balance 499 in different directions with the former promoting more measured, goal-directed responding and 500 the latter, through reducing value SNR, prompting more rapid responses divorced from goal 501 values. Of course, this is a speculation and our experimental design does not allow us to test it 502 directly. 503
Certain limitations must be acknowledged. The between-subject design prevented analyses of 504 potential brain-behaviour correlations. Further, while pharmacological fMRI is widely used and 505 provides a targeted, non-invasive way of investigating neural processes, there are some basic 506 limitations of the approach. Given the limited data on dose and receptor occupancy 507 relationships for these agents, doses and administration protocols are based on the known 508 pharmacokinetics of these drugs and on previous studies that have successfully used them to believed to vary depending on the exact drug used, its concentration, the basal level of 516 dopamine in the system (discussed in Frank and O'Reilly (2006)), as well as on the brain area of 517 the studied effect, given the different distribution of post-and pre-synaptic receptors 518 throughout the brain (Kilts et al., 1987) . It is not possible to entirely exclude the possibility of 519 auto-receptors effects in our study though the directionally of our effects does instil some 520 confidence that we are seeing predominantly post-synaptic effects. 521
In summary, we explored the role of dopamine in the neural representation of value without the 522 confound of learning. We investigated the direct role of dopamine in the expression of value that has been already learned through life experience, and whose accurate expression is a requisite 524 of goal-directed behaviour. Our results suggest that dopamine enhances the neural 525 representation of value in the IPS. The effect predominates towards the end of the valuation 526 process, at the point where the decision becomes explicit in action. These findings provide a 527 dopamine-dependent mechanism underlying impaired decision-making in healthy individuals 528 and clinical populations with reduced dopamine levels. 529 Full details of the activation foci are given in Table 1 . 703 Table 3 . Regions with an enhanced neural representation of value under bromocriptine, 740 compared to sulpiride. 741 Table 4 . Activation peak exhibiting a time-by-treatment interaction in the left IPG/IPS. 742 p<0.001 uncorrected, extent k>20 voxels. p<0.05 whole-brain FWE correction for multiple comparisons at the cluster-level (p<0.001 uncorrected threshold). p<0.05 small-volume FWE correction within a 10mm sphere around the peak voxel in the left IPG/IPS (-50,-50, 46) which showed an effect of drug across the entire bidding trial (model 1).
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